10x Genomics
10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology and to advance human health. Cited in more than 7,000 research papers, their innovative single-cell, spatial and in situ technologies enable discoveries across oncology, immunology, neuroscience and more. 10x Genomics' talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents and software that analyze biological systems at a resolution that matches the complexity of biology.
Latest 10x Genomics Content
Product
Advertisement
Visium Spatial Gene Expression: Map Transcriptomes Within Tissue Context
With tools like Visium Spatial Gene Expression, researchers can access a multidimensional profile of the biology of a complex tissue section, measuring and mapping spatial gene expression while maintaining a clear view of the morphological context of the tissue.
Video
Single-Cell and Spatial Multiomics To Advance Basic and Translational Cancer Research
Speaking at 'The Landscape of Cancer Research', Abbey Cutchin, Manager, Oncology Segment Marketing at 10x Genomics, presented her talk on cancer progression and therapeutic resistance.
Product News
10x Genomics Launches Two New Products To Unlock Wider Range of Samples for Single Cell Analysis on Chromium
10x Genomics has announced the commercial availability of two new products designed to improve sample preparation workflow and broaden the adoption of the company's leading Chromium platform for single cell analysis: Fixed RNA Profiling and Nuclei Isolation Kits.
News
Potential Biomarker for Alzheimer’s Disease May Also Serve as Drug Target
Researchers have found a shift in the profile of specialized lipid mediators from pro-resolving to pro-inflammatory in the
cerebrospinal fluid of patients with cognitive impairment, ranging from subjective impairment to a diagnosis of Alzheimer’s. They propose that the lipid mediators could act as a potential biomarker for Alzheimer’s disease that may also serve as a therapeutic target.
cerebrospinal fluid of patients with cognitive impairment, ranging from subjective impairment to a diagnosis of Alzheimer’s. They propose that the lipid mediators could act as a potential biomarker for Alzheimer’s disease that may also serve as a therapeutic target.
Product News
Element Biosciences Launches the AVITITM System To Democratize Access to Genomics
Element Biosciences Inc. has announced the commercial launch of the Element AVITI™ System, a benchtop sequencer offering an unrivaled combination of performance, cost and flexibility.
Advertisement
